Status:

NOT_YET_RECRUITING

Comparison of Efficacy of Oral Amoxicillin Versus Intravenous Ceftriaxone

Lead Sponsor:

RESnTEC, Institute of Research

Conditions:

Community-acquired Pneumonia

Eligibility:

All Genders

2-5 years

Phase:

NA

Brief Summary

The efficacy of oral amoxicillin is considered equal to that of ceftriaxone in community-acquired pneumonia among children. Also, there are some factors that contradict the usage of ceftriaxone, like ...

Detailed Description

The efficacy of oral amoxicillin is considered equal to that of ceftriaxone in community-acquired pneumonia among children. Also, there are some factors that contradict the usage of ceftriaxone, like ...

Eligibility Criteria

Inclusion

  • Children of both gender
  • Aged from 2 to 5 years
  • With fever \>37.5 C (99.5 F)
  • Will be presented with symptoms and signs of uncomplicated community acquired pneumonia

Exclusion

  • Children requiring ICU care (having cyanosis SpO2 \< 85% requiring intubation within first day of admission or in state of shock)
  • Children with conditions like congenital heart disease, chronic lung disease, chronic kidney disease, severe malnutrition, asthma, foreign bodies, sickle cell disease, and immunodeficiency
  • Children with underlying anatomical disorders of the lung like pulmonary sequestration, tracheoesophageal fistula or congenital cystic adenoid malformation
  • Children already on antibiotics
  • Presence of any complication of community acquired pneumonia
  • Patients having symptoms of multi-organ involvement/sepsis
  • Hypersensitivity to Amoxicillin or Ceftriaxone
  • Other co-existing infections like dengue, malaria, or measles

Key Trial Info

Start Date :

October 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 30 2025

Estimated Enrollment :

114 Patients enrolled

Trial Details

Trial ID

NCT06532409

Start Date

October 1 2024

End Date

September 30 2025

Last Update

August 1 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Children Hospital

Lahore, Punjab Province, Pakistan, 54000